First Wilshire Securities Management’s ANI Pharmaceuticals ANIP Stock Holding History

First Wilshire Securities Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-56,244	Closed	-$3.03M	–	86
2023 Q2	$3.03M	Sell	56,244 -150,084	-73%	-$6.65M	1.04%	28
2023 Q1	$8.2M	Sell	206,328 -155,119	-43%	-$6.54M	2.8%	12
2022 Q4	$14.5M	Sell	361,447 -5,879	-2%	-$221K	5.09%	5
2022 Q3	$11.8M	Sell	367,326 -428	-0.1%	-$14.7K	4.78%	6
2022 Q2	$10.9M	Buy	367,754 +39,825	+12%	+$1.15M	4.07%	7
2022 Q1	$9.22M	Sell	327,929 -565	-0.2%	-$21.1K	3.24%	8
2021 Q4	$15.1M	Sell	328,494 -5,192	-2%	-$223K	4.72%	6
2021 Q3	$11M	Buy	333,686 +94,585	+40%	+$2.94M	3.63%	8
2021 Q2	$8.38M	Buy	239,101 +19,139	+9%	+$651K	2.93%	9
2021 Q1	$7.95M	Buy	219,962 +59,166	+37%	+$1.85M	2.97%	8
2020 Q4	$4.67M	Buy	+160,796	New	+$4.6M	1.88%	17

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Wilshire Securities Management's ANIP Position: Q3 2023 in Review

First Wilshire Securities Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2023, closing a stake of 56,244 shares — an estimated $3.03M sold.

First Wilshire Securities Management first reported a position in ANIP in Q4 2020 and held it in 11 quarters. The position peaked at $15.1M in Q4 2021. 185 funds tracked by Wall St. Rank hold ANIP as of Q3 2023.

First Wilshire Securities Management reported no remaining ANI Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
First Wilshire Securities Management sold 56,244 ANI Pharmaceuticals shares in Q3 2023, an estimated $3.03M.
First Wilshire Securities Management first reported a position in ANI Pharmaceuticals in Q4 2020 and held it in 11 quarters.
First Wilshire Securities Management's ANI Pharmaceuticals position peaked at $15.1M in Q4 2021.
185 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2023.

Based on First Wilshire Securities Management's 13F filing for Q3 2023, filed 14 Nov 2023.